No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs17014923 |
chr2:127841930-127841931 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs553455230 |
chr2:127841932-127841933 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs563574888 |
chr2:127841935-127841936 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs571931007 |
chr2:127841942-127841943 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs58402148 |
chr2:127841945-127841946 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
6 |
rs530560826 |
chr2:127841946-127841947 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs532362048 |
chr2:127842022-127842023 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs546208189 |
chr2:127842023-127842024 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs550295658 |
chr2:127842090-127842091 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs563024546 |
chr2:127842157-127842158 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs17014926 |
chr2:127842161-127842162 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs11693422 |
chr2:127842162-127842163 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
13 |
rs144083006 |
chr2:127842165-127842166 |
Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Genic enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs34438272 |
chr2:127842205-127842206 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs139910938 |
chr2:127842207-127842208 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs547508373 |
chr2:127842229-127842230 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs143505374 |
chr2:127842254-127842255 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs539416458 |
chr2:127842255-127842256 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs75023436 |
chr2:127842267-127842268 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs536313498 |
chr2:127842293-127842294 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs116144099 |
chr2:127842304-127842305 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs188790400 |
chr2:127842346-127842347 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs11691237 |
chr2:127842383-127842384 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
24 |
rs571869033 |
chr2:127842395-127842396 |
Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs540866979 |
chr2:127842405-127842406 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs553828662 |
chr2:127842437-127842438 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs576958022 |
chr2:127842461-127842462 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs545998749 |
chr2:127842466-127842467 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs77262456 |
chr2:127842477-127842478 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs531614625 |
chr2:127842518-127842519 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs542470068 |
chr2:127842519-127842520 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs562412504 |
chr2:127842523-127842524 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs139103183 |
chr2:127842549-127842550 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs74915682 |
chr2:127842557-127842558 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs564152038 |
chr2:127842586-127842587 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs11694743 |
chr2:127842607-127842608 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
37 |
rs549630949 |
chr2:127842613-127842614 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs531028672 |
chr2:127842614-127842615 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs534884581 |
chr2:127842616-127842617 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs181594860 |
chr2:127842618-127842619 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs549250007 |
chr2:127842619-127842620 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs186415110 |
chr2:127842639-127842640 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs552808250 |
chr2:127842651-127842652 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs557496271 |
chr2:127842696-127842697 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs577439038 |
chr2:127842732-127842733 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs13430214 |
chr2:127842751-127842752 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs116457083 |
chr2:127842790-127842791 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs537498527 |
chr2:127842818-127842819 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs576377978 |
chr2:127842824-127842825 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs62158723 |
chr2:127842874-127842875 |
Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|